MRTX1133 - Mirati
"MRTX1133 is an selective non-covalent inhibitor of KRAS G12D #Targets21" (@ElizSMcKenna) Oct 9, 2021 
Oncology KRAS
https://twitter.com/ElizSMcKenna/status/1446878522631409666
 
Oct 9, 2021
 
 
a7b4e58a-1c59-4a2c-af24-9bec742abcb4.jpg